I wouldn't be surprised to see the shorts make one

I wouldn't be surprised to see the shorts make one more attempt to shake out the weak hands. The thing is, there is a large part of this float in the strong hands of people who post here. Biomanbaba figured out that we control probably 10 million of the approximately 21 million of the real float.

However, I feel sure that much of this shorting is illegal naked shorting. As DrFeelgood pointed out, they have several days before they have to cover those naked shorts before the Regulation SHO rules come in and they have to report "failure to deliver" aka naked shorting (not that these jokers bother complying with that regulation all the time.) so they have another day that they can sit there short before it even begins to be a problem for them.

If you haven't read the sticky note stuff at the top of this page, please do. CTIX is not a one-trick pony. In addition to Kevetrin, there is the psoriasis drug, Prurisol, which I think may be the next upward impetus to the stock price. There should be news soon, something like "CTIX announces that Dr. Reddy's Laboratories has synthesized the test batch of Prurisol, which is being submitted to the FDA for testing. This is the final step before human trials commence."

Unlike most other small biotechs, CTIX has the "insurance policy" of Prurisol. If Kevetrin were to fail in human testing, there is another drug, Prurisol, that will already be in or close to human trials. This is an added layer of protection for CTIX shareholders. We are not totally dependent on Kevetrin as the only source of a potential joint venture or buyout.